No More Side Effects: Nexalin’s Non-Invasive Approach to Treating Depression & PTSD

Videos

October 20, 2024 1:55 PM

Nexalin Technology Secures USPTO Patent for Deep Intracranial Frequency Stimulation (DIFS™) Technology in Treating Substance Use Disorders

April 14, 2025

Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial

April 2, 2025

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on April 3

March 26, 2025